ASSET PURCHASE AGREEMENT between GENOMIC HEALTH, INC. and MDXHEALTH SA dated as of August 2, 2022Asset Purchase Agreement • April 25th, 2023 • MDxHealth SA • Services-medical laboratories • Delaware
Contract Type FiledApril 25th, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of August 2, 2022, is entered into between Genomic Health, Inc., a Delaware corporation (“Seller”), and MDxHealth SA, a limited liability company (société anonyme) organized and existing under the laws of Belgium (“Buyer”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 25th, 2023 • MDxHealth SA • Services-medical laboratories • New York
Contract Type FiledApril 25th, 2023 Company Industry JurisdictionTHIS LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this “Agreement”) dated as of August 2, 2022 (the “Effective Date”) among INNOVATUS LIFE SCIENCES LENDING FUND I, LP, a Delaware limited partnership, as collateral agent (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”), and the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including INNOVATUS LIFE SCIENCES LENDING FUND I, LP in its capacity as a Lender, and MDXHEALTH SA, a limited liability company existing under the laws of Belgium, having its registered office at Rue d’Abhooz 31, 4040 Herstal, Belgium and registered under company number 0470.292.440 RLP Liège, division Liège (“Parent”) and MDXHEALTH, INC., a Delaware corporation with offices located at 15279 Alton Parkway, Suite 100, Irvine, CA 92618 (“US Sub”; together with Parent, individually and collectively, jointly and severall
AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 25th, 2023 • MDxHealth SA • Services-medical laboratories
Contract Type FiledApril 25th, 2023 Company IndustryThis AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”), dated as of January 1, 2023, is entered into between Genomic Health, Inc., a Delaware corporation (“GHI” or “Seller”), and MDxHealth SA, a limited liability company (société anonyme) organized and existing under the laws of Belgium (“MDx” or “Buyer”). Capitalized terms used but not defined herein shall have the respective meanings given to such terms in the Purchase Agreement (as defined below).